World Health Organisation Tender

Unitaid Is A Global Health Agency Engaged In Finding Innovative Solutions To Prevent, Diagnose, And Treat Diseases More Quickly, Affordably And Effectively, In Low- And Middle-income Countries (lmics). Its Work Includes Funding Initiatives To Address Major Diseases Such As Hiv/aids, Malaria, And Tuberculosis, As Well As Hiv Co-infections And Co-morbidities. This Call For Expression Of Interest (eoi) Is Issued To Provide An Opportunity For Manufacturing Companies With Generic Formulations Of Liposomal Amphotericin B (l-amb) In Advanced Stages Of Development And/or Ready For Commercialization For Technical, Regulatory And/or Financial Support To Accelerate The Commercialization Of A Quality Assured Product, To Express Their Interest And Provide Relevant Information Which Will Help Unitaid To Determine How To Improve Access To Quality Assured L-amb In Low- And Middle-income Countries (lmics) At An Affordable Price. We Kindly Invite You To Participate In This Eoi through The Enclosed Document, To Be Submitted To Unitaid-proc@who.int By 26 July 2022, 17:00 (cet). Please Note, Any Information Submitted In Response To This Eoi is Provided On A Voluntary Basis. Please Also Take Note Of Disclaimer Text On The Eoi cover Page. We Look Forward To Receiving Your Response. Kind Regards; Unitaid Team